$VNRX earnings: flat Q2 revenue, and the stock’s typical next-day swing has been 6.6%
How VNRX has reacted before
| Report | Next-day move |
|---|---|
| Aug 2026 | +0.7% |
| May 2026 | -9.1% |
| Apr 2026 | -1.0% |
| Nov 2025 | -6.6% |
| Aug 2025 | +7.9% |
| Mar 2025 | -9.0% |
| Nov 2024 | -5.6% |
Median absolute move 6.6% · higher 2 of 7 · n=7
VolitionRX Limited Common Stock maintains strong focus on product development and cost reduction despite flat Q2 revenue of $0.4 million year-over-year.
How $VNRX has reacted to earnings
| Report | Next-day |
|---|---|
| Aug 2026 | +0.7% |
| May 2026 | -9.1% |
| Apr 2026 | -1.0% |
| Nov 2025 | -6.6% |
| Aug 2025 | +7.9% |
| Mar 2025 | -9.0% |
| Nov 2024 | -5.6% |
Base rate (n=7):
- Median absolute next-day move: 6.6%
- Next day higher: 2 of 7
- Biggest up day: +7.9%
- Biggest down day: -9.1%